The global number of people with Alzheimer's disease (AD) doubles every 5 years. It has
been established that unless an effective treatment for AD is found, the incidence of AD will …

Background: Despite the extensive research in recent years, the current treatment modalities
for neurological disorders are suboptimal. Curcumin, a polyphenol majorly found in …

Objectives: Identify the risk factors associated with Alzheimer disease. Describe the atypical
presentations of Alzheimer disease. Summarize and differentiate between the preclinical …

The increase in life expectancy led to a significant rise in the prevalence of age-related
neurological diseases, such as cognitive impairment, dementia, and Alzheimer's disease …

Alzheimer's disease (AD) is a high-incidence neurodegenerative disorder, characterized by
cognitive impairment, memory loss, and psychiatric abnormalities. Ganoderma lucidum is a …

Alzheimer's disease (AD) is a neurodegenerative disorder that affects millions worldwide
and is expected to surge in prevalence due to aging populations. Frailty, characterized by …

Alzheimer's disease (AD), the most common form of dementia, is a striking example of the
connection between neurophysiological abnormalities and higher-order cognitive …

The AAA+ ATPase valosin containing protein (VCP) is essential for cell and organ
homeostasis, especially in cells of the nervous system. As part of a large network, VCP …

Alzheimer-type dementia (ATD) treatments face limitations in crossing the blood–brain
barrier and systemic adverse effects. Intranasal administration offers a direct route to the …

With the increase in the aging population, the global number of people with Alzheimer's
disease (AD) progressively increased worldwide. The situation is aggravated by the fact that …